每經AI快訊(xun)，10月(yue)10日，康辰藥業公告，公司控股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)東(dong)劉建(jian)華(hua)持(chi)有(you)的420萬(wan)股(gu)(gu)(gu)(gu)無限售條件流通股(gu)(gu)(gu)(gu)于2025年10月(yue)9日解除(chu)質(zhi)(zhi)押，占其(qi)所持(chi)股(gu)(gu)(gu)(gu)份比例(li)為(wei)(wei)(wei)8.43%，占公司總(zong)股(gu)(gu)(gu)(gu)本(ben)比例(li)為(wei)(wei)(wei)2.64%。解除(chu)質(zhi)(zhi)押后，劉建(jian)華(hua)累(lei)計質(zhi)(zhi)押公司股(gu)(gu)(gu)(gu)份數量(liang)(liang)為(wei)(wei)(wei)464.68萬(wan)股(gu)(gu)(gu)(gu)，占其(qi)持(chi)股(gu)(gu)(gu)(gu)數量(liang)(liang)比例(li)為(wei)(wei)(wei)9.33%，占公司總(zong)股(gu)(gu)(gu)(gu)本(ben)比例(li)為(wei)(wei)(wei)2.92%。